Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.3729
-0.0055 (-1.45%)
At close: Jul 10, 2025, 4:00 PM
0.3798
+0.0069 (1.85%)
After-hours: Jul 10, 2025, 7:54 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $25.00 million as of July 10, 2025. Its market cap has decreased by -86.34% in one year.
Market Cap
25.00M
Enterprise Value
-44.98M
1-Year Change
-86.34%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $25.00M, a decrease of -97.67%. That is a compound annual growth rate of -52.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 25.37M | -64.17% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |